Candesartan Cilexetil (candesartan cilexetil): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Candesartan Cilexetil 16 mg Tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults

• Treatment of hypertension in children and adolescents aged 6 to < 18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 16 mg tablets

Treatment of essential hypertension in adults.

Treatment of hypertension in children and adolescents aged 6 to <18 years.

Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 16 mg Tablets (Arrow)

Candesartan is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to Angiotensin Converting Enzyme (ACE) inhibitors or when ACE inhibitors are not tolerated.

Candesartan cilexetil 16mg tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 2mg tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1).

Candesartan Cilexetil 32 mg Tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults

• Treatment of hypertension in children and adolescents aged 6 to < 18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 32 mg tablets

Treatment of essential hypertension in adults.

Treatment of hypertension in children and adolescents aged 6 to <18 years.

Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 32 mg Tablets (Arrow)

Candesartan is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to Angiotensin Converting Enzyme (ACE) inhibitors or when ACE inhibitors are not tolerated.

Candesartan cilexetil 32mg tablets

Candesartan cilexetil is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1).

Candesartan Cilexetil 4 mg Tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults

• Treatment of hypertension in children and adolescents aged 6 to < 18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)--inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 4 mg tablets

Treatment of essential hypertension in adults.

Treatment of hypertension in children and adolescents aged 6 to <18 years.

Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 4 mg Tablets (Arrow)

Candesartan is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to Angiotensin Converting Enzyme (ACE) inhibitors or when ACE inhibitors are not tolerated.

Candesartan cilexetil 4mg tablets

Candesartan cilexetil is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1).

Candesartan Cilexetil 8 mg Tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults

• Treatment of hypertension in children and adolescents aged 6 to < 18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 8 mg tablets

Treatment of essential hypertension in adults.

Treatment of hypertension in children and adolescents aged 6 to <18 years.

Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see sections 4.2, 4.4, 4.5 and 5.1).

Candesartan cilexetil 8 mg Tablets (Arrow)

Candesartan is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of adult patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction ≤ 40%) as add-on therapy to Angiotensin Converting Enzyme (ACE) inhibitors or when ACE inhibitors are not tolerated.

Candesartan cilexetil 8mg tablets

Candesartan Cilexetil is indicated for the:

• Treatment of essential hypertension in adults.

• Treatment of hypertension in children and adolescents aged 6 to <18 years.

• The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when ACE-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated (see Sections 4.2, 4.4, 4.5 and 5.1).


Route of administration: Oral
Molecule: candesartan cilexetil

Patients' opinions on Candesartan Cilexetil

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

See the fact sheet
Fact sheet

Heart failure

See the fact sheet